Possibilities and limitations of reaction product analysis

J Owen¹

Affiliations

Review

J Owen. Ann N Y Acad Sci. 1992.

. 1992 Dec 4:667:305-9.

doi: 10.1111/j.1749-6632.1992.tb51631.x.

J Owen¹

¹ Department of Medicine, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157.

No abstract available

Similar articles

Fibrinogen- and fibrin-degradation products during fibrinolytic therapy.
Francis CW, Kornberg A. Francis CW, et al. Ann N Y Acad Sci. 1992 Dec 4;667:310-23. doi: 10.1111/j.1749-6632.1992.tb51632.x. Ann N Y Acad Sci. 1992. PMID: 1309052 Review. No abstract available.
Biomarkers versus viscoelastic testing for the detection of fibrinolysis.
Görlinger K. Görlinger K. ANZ J Surg. 2020 Apr;90(4):411-412. doi: 10.1111/ans.15649. ANZ J Surg. 2020. PMID: 32339432 No abstract available.
Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
Feddersen C. Feddersen C. Scand J Clin Lab Invest Suppl. 1983;166:1-60. Scand J Clin Lab Invest Suppl. 1983. PMID: 6226084 No abstract available.
Implications of fibrinogenolysis in patients with closed head injury.
Kushimoto S, Shibata Y, Yamamoto Y. Kushimoto S, et al. J Neurotrauma. 2003 Apr;20(4):357-63. doi: 10.1089/089771503765172318. J Neurotrauma. 2003. PMID: 12866815
[Blood coagulation studies to discover the pathologically increased fibrinolytic activity of the blood that causes hemorrhage].
Enev N. Enev N. Vutr Boles. 1978;17(3):41-5. Vutr Boles. 1978. PMID: 150133 Review. Bulgarian. No abstract available.

Nerve involvement in fluid transport in the inflamed rat jejunum.
Jodal M, Wingren U, Jansson M, Heidemann M, Lundgren O. Jodal M, et al. Gut. 1993 Nov;34(11):1526-30. doi: 10.1136/gut.34.11.1526. Gut. 1993. PMID: 8244137 Free PMC article.